Search

Your search keyword '"Esteves SC"' showing total 327 results

Search Constraints

Start Over You searched for: Author "Esteves SC" Remove constraint Author: "Esteves SC"
327 results on '"Esteves SC"'

Search Results

3. Re: Reproductive Outcomes of Testicular Versus Ejaculated Sperm for Intracytoplasmic Sperm Injection Among Men with High Levels of DNA Fragmentation in Semen: Systematic Review and Meta- Analysis

4. Microdissection Testicular Sperm Extraction (Micro-TESE): Results of a Large Series from India

9. Cryopreservation of human spermatozoa with pentoxifylline improves the post-thaw agonist-induced acrosome reaction rate.

10. Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology

12. A multi-faceted exploration of unmet needs in the continuing improvement and development of fertility care amidst a pandemic.

13. From pathophysiology to practice: addressing oxidative stress and sperm DNA fragmentation in Varicocele-affected subfertile men.

14. Non-Obstructive Azoospermia and Intracytoplasmic Sperm Injection: Unveiling the Chances of Success and Possible Consequences for Offspring.

15. Editorial: Reproductive microbiome and its interplay with the environment.

16. To the editor: understanding presperm retrieval hormonal treatment effectiveness in nonobstructive azoospermia through real-world evidence.

18. Clinical factors associated with unexpected poor or suboptimal response in Poseidon criteria patients.

19. Clinical factors impacting microdissection testicular sperm extraction success in hypogonadal men with nonobstructive azoospermia.

20. Sperm DNA Fragmentation: causes, evaluation and management in male infertility.

21. Eligibility for the medical therapy among men with non-obstructive azoospermia-Findings from a multi-centric cross-sectional study.

23. High prevalence of low prognosis by the POSEIDON criteria in women undergoing planned oocyte cryopreservation.

24. APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function.

25. Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for male infertility.

27. Significance of serum AMH and antral follicle count discrepancy for the prediction of ovarian stimulation response in Poseidon criteria patients.

28. Effect of environmental factors on seminal microbiome and impact on sperm quality.

29. Effect of varicocele and varicocelectomy on sperm deoxyribonucleic acid fragmentation rates in infertile men with clinical varicocele.

30. Correction to: The HERA (Hyper‑response Risk Assessment) Delphi consensus for the management of hyper‑responders in in vitro fertilization.

32. Prevalence and clinical implications of biochemical hypogonadism in patients with nonobstructive azoospermia undergoing infertility evaluation.

33. The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization.

34. Surgically retrieved spermatozoa for ICSI cycles in non-azoospermic males with high sperm DNA fragmentation in semen.

35. Improving standard practices in studies using results from basic human semen examination.

36. The true natural cycle frozen embryo transfer - impact of patient and follicular phase characteristics on serum progesterone levels one day prior to warmed blastocyst transfer.

37. Male infertility.

38. Comparison of the efficacy of subcutaneous versus vaginal progesterone using a rescue protocol in vitrified blastocyst transfer cycles.

39. Total fertilization failure after ICSI: insights into pathophysiology, diagnosis, and management through artificial oocyte activation.

40. What is varicocele?

41. Towards infertility care on equal terms: a prime time for male infertility.

42. The Fischer protocol for assisted reproductive technology treatment: Real-world data experience comparing elective single versus double embryo transfer with or without comprehensive chromosome screening.

43. Exploring the potential impact of human papillomavirus on infertility and assisted reproductive technology outcomes.

44. The HERA (Hyper-response Risk Assessment) Delphi consensus definition of hyper-responders for in-vitro fertilization.

46. Risk of genetic and epigenetic alteration in children conceived following ART: Is it time to return to nature whenever possible?

47. Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models.

48. COVID-19 and its treatments: lights and shadows on testicular function.

49. A drop in serum progesterone from oocyte pick-up +3 days to +5 days in fresh blastocyst transfer, using hCG-trigger and standard luteal support, is associated with lower ongoing pregnancy rates.

50. Male infertility and gonadotropin treatment: What can we learn from real-world data?

Catalog

Books, media, physical & digital resources